“Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer
These findings support the relevance and importance of non-OS endpoints to Canadians with early-stage cancer and highlight participants' desire for rapid approval of treatments with demonstrated improvements in non-OS endpoints.
Authors
- Robert Bick
- Shelagh M. Szabo (ORCID: https://orcid.org/0000-0002-9044-3192)
- Stephanie Snow (ORCID: https://orcid.org/0000-0003-3847-0289)
- Sarah R. Walker (ORCID: https://orcid.org/0000-0001-6465-241X)
- Frances Simbulan (ORCID: https://orcid.org/0009-0008-5555-690X)
- Andrew McMillan (ORCID: https://orcid.org/0009-0000-1101-3729)
- Eon Ting
- Evelyn Griffin (ORCID: https://orcid.org/0009-0007-9520-6376)
Institutions
- Dalhousie University (CA)
- Cancer Care Ontario (CA)
- Horizons Community Solutions (US)
- AstraZeneca (Canada) (CA)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3390/cancers17193260
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00